Evidence map›Paper›PMID 37754778›Full record

ArticleInternational journal of neonatal screening2023

Whole-Genome Sequencing Can Identify Clinically Relevant Variants from a Single Sub-Punch of a Dried Blood Spot Specimen.

David J McBride, Claire Fielding, Taksina Newington, Alexandra Vatsiou, Harry Fischl, Maya Bajracharya, Vicki S Thomson, Louise J Fraser, Pauline A Fujita, Jennifer Becq and 4 more

Abstract read
In one paragraph

Article in International journal of neonatal screening, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

David J McBrideIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.ORCID 0009-0006-5482-8040
Claire FieldingIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Taksina NewingtonIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Alexandra VatsiouIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Harry FischlIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Maya BajracharyaIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Vicki S ThomsonIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Louise J FraserIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Pauline A FujitaIllumina Inc., San Diego, CA 92122, USA.
Jennifer BecqIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Zoya KingsburyIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Mark T RossIllumina Cambridge Ltd., Cambridge CB21 6DF, UK.
Stuart J MoatWales Newborn Screening Laboratory, University Hospital of Wales, Cardiff CF14 4XW, UK.ORCID 0000-0002-3592-2254
Sian MorganAll Wales Genetics Laboratory, University Hospital of Wales, Cardiff CF14 4XW, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The collection of dried blood spots (DBS) facilitates newborn screening for a variety of rare, but very serious conditions in healthcare systems around the world. Sub-punches of varying sizes (1.5-6 mm) can be taken from DBS specimens to use as inputs for a range of biochemical assays. Advances in DNA sequencing workflows allow whole-genome sequencing (WGS) libraries to be generated directly from inputs such as peripheral blood, saliva, and DBS. We compared WGS metrics obtained from libraries generated directly from DBS to those generated from DNA extracted from peripheral blood, the standard input for this type of assay. We explored the flexibility of DBS as an input for WGS by altering the punch number and size as inputs to the assay. We showed that WGS libraries can be successfully generated from a variety of DBS inputs, including a single 3 mm or 6 mm diameter punch, with equivalent data quality observed across a number of key metrics of importance in the detection of gene variants. We observed no difference in the performance of DBS and peripheral-blood-extracted DNA in the detection of likely pathogenic gene variants in samples taken from individuals with cystic fibrosis or phenylketonuria. WGS can be performed directly from DBS and is a powerful method for the rapid discovery of clinically relevant, disease-causing gene variants.

Indexed as

cystic fibrosisDNA sequencingdried blood spotsnewborn screeningphenylketonuriawhole genome sequencing

Identifiers

PMID37754778
PMCPMC10532340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.